Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors

标题
Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors
作者
关键词
-
出版商
Dustri-Verlgag Dr. Karl Feistle
发表日期
2011-12-23
DOI
10.5414/cpp50076

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started